The use of rivaroxaban for chemical thromboprophylaxis following total knee replacement

Knee

Volumn 20, Issue 6, 2013, Pages 397-400

  Rath, N K ^a   Goodson, M W ^a   White, S P ^a   Forster, M C ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Pulmonary embolism; Rivaroxaban; Thromboprophylaxis; Total knee replacement; Wound complication

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; RIVAROXABAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG USE; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; THROMBOSIS PREVENTION; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM; WOUND COMPLICATION;

PULMONARY EMBOLISM; RIVAROXABAN; THROMBOPROPHYLAXIS; TOTAL KNEE REPLACEMENT; WOUND COMPLICATION;

AGED; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, KNEE; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MORPHOLINES; POSTOPERATIVE COMPLICATIONS; PRIMARY PREVENTION; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; THIOPHENES; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84887238791     PISSN: 09680160     EISSN: 18735800     Source Type: Journal    
DOI: 10.1016/j.knee.2013.01.006     Document Type: Article

References (16)

1. Fender D., Harper W.M., Thompson J.R., Gregg P.J. Mortality and fatal pulmonary embolism after primary total hip replacement. Results from a regional hip register. J Bone Joint Surg Br 1997, 79-6:896-899.
2. Clayton R.A.E., Gaston P., Watts A.C., Howie C.R. Thromboembolic disease after total knee replacement: experience of 5100 cases. Knee 2009, 16-1:18-21.
3. Howie C.R., Hughes H., Watss A.C. Venous thrombosis and pulmonary embolism associated with hip and knee joint replacement over a ten year period: a population based study. J Bone Joint Surg Br 2005, 87-B:1675-1680.
4. Khaw F.M., Moran C.G., Pinder I.M., Smith S.R. The incidence of fatal pulmonary embolism after knee replacement with no prophylactic anticoagulation. J Bone Joint Surg Br 1993, 75-6:940-941.
5. Khan A., Emberson J., Dowd G.S. Standardized mortality ratios and fatal pulmonary embolism rates following total knee replacement: a cohort of 936 consecutive cases. J Knee Surg 2002, 15-4:219-222.
6. Douketis J.D., Eikelboom J.W., Quinlan D.J., Willan A.R., Crowther M.A. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 2002, 162-13:1465-1471.
7. House of Commons Health Committee The prevention of venous thromboembolism in hospitalised patients [Date last assessed 25/04/2012]. http://www.publications.parliament.uk/pa/cm200405/cmselect/cmhealth/99/99.pdf.
8. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital [Date last assessed 25/04/2012]. http://guidance.nice.org.uk/CG92/Guidance/pdf/English.
9. Eriksson B.I., Borris L.C., Friedman R.J., Haas S., Huisman M.V., Kakkar A.K., et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008, 358-26:2765-2775.
10. Kakkar A.K., Brenner B., Dahl O.E., Eriksson B.I., Mouret P., Muntz J., et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008, 372-9632:31-39.
11. Lassen M.R., Ageno W., Borris L.C., Lieberman J.R., Rosencher N., Bandel T.J., et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008, 358-26:2776-2786.
12. Turpie A.G., Lassen M.R., Davidson B.L., Bauer K.A., Gent M., Kwong L.M., et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet 2009, 373-9676:1673-1680.
13. Jameson S.S., Bottle A., Malviya A., Muller S.D., Reed M.R. The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb. J Bone Joint Surg Br 2010, 92-1:123-129.
14. Lotke P.A. Rivaroxaban for thromboprophylaxis. N Engl J Med 2008, 359-20:2174-2175. [6].
15. Maderazo E.G., Judson S., Pasternak H. Late infections of total joint prostheses. A review and recommendations for prevention. Clin Orthop Relat Res 1988, 229:131-142.
16. Cusick L.A., Beverland D.E. The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients. J Bone Joint Surg Br 2009, 91-5:645-648.